Arrowhead Pharmaceuticals Inc
Biotechnology
Healthcare
ARWR
124 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
9.76
52 week high
29.54
high
12.47
52 week low
9.99
low
9.64
growth
-48.58 %
previous Close
9.99
P/E ratio
-9
market cap
2.46 B
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-170.54 M
0.15 %
eps
-1.37 %
0.72 %
eps surprise
-48.59 %
net profit margin
-17053600000.00 %
0.00 %
operating incoming
-162.20 M
7.91 %
net change in cash
33.29 M
157.09 %
cash on hand
103 M
47.96 %
cost of revenue
0.00 %
top top